Uniphar plc (FRA:0NR)

Market Cap	992.87M +78.3%
Revenue (ttm)	2.89B +7.7%
Net Income	66.31M +46.8%
EPS	0.25 +49.6%
Shares Out	n/a
PE Ratio	14.97
Forward PE	15.68
Dividend	0.02 (0.51%)
Ex-Dividend Date	Sep 11, 2025

Volume	n/a
Average Volume	360
Open	3.960
Previous Close	3.840
Day's Range	3.845 - 3.965
52-Week Range	1.996 - 4.165
Beta	n/a
RSI	62.15
Earnings Date	Feb 25, 2026

About Uniphar

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source throug...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1967
• Employees: 3,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0NR

Financial Performance

In 2024, Uniphar's revenue was 2.77 billion, an increase of 8.51% compared to the previous year's 2.55 billion. Earnings were 64.20 million, an increase of 43.26%.